Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [F-18] fluorodeoxyglucose

被引:71
作者
Kole, AC
Nieweg, OE
vanGinkel, RJ
Pruim, J
Hoekstra, HJ
Paans, AMJ
Vaalburg, W
Koops, HS
机构
[1] UNIV GRONINGEN HOSP,DEPT SURG ONCOL,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,PET CTR,NL-9700 RB GRONINGEN,NETHERLANDS
[3] NETHERLANDS CANC INST,DEPT SURG,AMSTERDAM,NETHERLANDS
关键词
positron emission tomography; sarcoma; fluorodeoxyglucose; detection; recurrence;
D O I
10.1007/BF02316811
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is often difficult to detect a local recurrence of soft-tissue sarcomas due to disturbance of the normal anatomy by previous surgery and radiotherapy. The aim of this study was to assess the value of positron emission tomography (PET) with [F-18]fluoro3-deoxy-D-glucose (FDG) for detecting local recurrences. Methods: In the period 1992-1995, 17 patients with proven or suspected local recurrence of soft-tissue sarcoma were examined using FDG-PET. Fifteen of these patients were ultimately proven to have a recurrence. Results: Recurrence was visualized in 14 patients (93%). Small tumors (maximum diameter 0.5 cm) were as easily visible as large lesions (maximum diameter 20 cm). In one patient the PET scan was positive, but the recurrence could not be proven histologically. Recurrence was proven 1 year later. A recurrent low-grade liposarcoma was not visualized. The two patients with benign lesions had a negative PET scan. The mean glucose metabolic rate was calculated to be 13.2 mu mol/100 g/min (range 1.9-28.4). A correlation was found between the histological malignancy grade and the metabolic rate (p < 0.05; Kruskal-Wallis). Conclusion: PET with FDG is a useful addition to the diagnostic armamentarium for detecting local recurrence of soft-tissue sarcomas and provides an indication of the malignancy grade of the recurrent lesion.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 37 条
[1]  
ADLER LP, 1991, J NUCL MED, V32, P1508
[2]   GRADING LIPOSARCOMAS WITH PET USING [F-18] FDG [J].
ADLER, LP ;
BLAIR, HF ;
WILLIAMS, RP ;
PATHRIA, MN ;
MAKLEY, JT ;
JOYCE, MJ ;
ALKAISI, N ;
MIRALDI, F .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) :960-962
[3]  
ALAVI JB, 1988, CANCER, V62, P1074, DOI 10.1002/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO
[4]  
2-H
[5]  
COINDRE JM, 1986, CANCER, V58, P306, DOI 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO
[6]  
2-7
[7]   GLUCOSE-UTILIZATION OF CEREBRAL GLIOMAS MEASURED BY [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
DICHIRO, G ;
DELAPAZ, RL ;
BROOKS, RA ;
SOKOLOFF, L ;
KORNBLITH, PL ;
SMITH, BH ;
PATRONAS, NJ ;
KUFTA, CV ;
KESSLER, RM ;
JOHNSTON, GS ;
MANNING, RG ;
WOLF, AP .
NEUROLOGY, 1982, 32 (12) :1323-1329
[8]  
ENZINGER FM, 1988, SOFT TISSUE TUMORS
[9]   PET EVALUATION OF SOFT-TISSUE MASSES WITH F-18 FLUORO-2-DEOXY-D-GLUCOSE [J].
GRIFFETH, LK ;
DEHDASHTI, F ;
MCGUIRE, AH ;
MCGUIRE, DJ ;
PERRY, DJ ;
MOERLEIN, SM ;
SIEGEL, BA .
RADIOLOGY, 1992, 182 (01) :185-194
[10]  
HABERKORN U, 1991, J NUCL MED, V32, P1548